Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

In vitro potential of human mesenchymal stem cells for corneal epithelial regeneration.

Nieto-Nicolau N., Martín-Antonio B., Müller-Sánchez C., Casaroli-Marano RP.

Laboratory Study on Chronic Wound, published in Regen Med (2020) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Regen Med (2020)
Country
England
Reported sample size
—
Source database
PubMed
PMID
32352350
DOI
10.2217/rme-2019-0067

Abstract (original English)

Aim: To determine the potential of mesenchymal stem cells (MSC) for corneal epithelial regeneration in vitro . Materials & methods: Bone marrow MSC (BM-MSC) and adipose tissue MSC were analyzed for corneal epithelial and mesenchymal markers, using limbal stem cells and corneal cells as controls. MSC with better potential were cultured with specific mediums for epithelial induction. Transepithelial electric resistance and wound healing assay with human corneal epithelial cells were performed. Results: BM-MSC showed better potential, increased corneal markers, and higher transepithelial electric resistance values when induced with limbal epithelial culture medium. Induced BM-MSC promoted better wound healing of human corneal epithelial cells by paracrine secretion. Conclusion: BM-MSC has potential for corneal epithelial induction in a protocol compatible with human application.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueBone Marrow CellsCell DifferentiationCell MovementCell ProliferationCoculture TechniquesCorneal DiseasesEpithelium, CornealHumansIn Vitro Techniques

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research